About CALTH

  • 2022

    • January

      AllCheck COVID19 Ag, MFDS listed

  • 2021

    • January

      Investment : USD 7M

    • May

      Factory establishment in Gunpo-si

    • June

      Selected for R&D project by the Ministry of SMEs and Stratups

    • October

      Launched Influneza immunodiagnostic reagent

      · AllCheck Influenza A+B

    • November

      KONEX listed

  • 2020

    • January

      Acquired the biosafety research facility level 2

    • May

      Launched COVID-19 immunodiagnostic reagent

      · AllCheck COVID-19 IgG/IgM

      Investment : USD 2.3M

      Acquired ISO13485 Certificate (TÜV SÜD)

    • June

      Selected for 2nd step of “Collabo R&D Project” by the Ministry of SMEs and Startups

    • October

      Launched COVID-19 immunodiagnostic reagent

      · AllCheck COVID19 Ag

  • 2019

    • May

      Investment : USD 3M

    • June

      Selected for “Collabo R&D Project” by the Ministry of SMEs and Startups

    • August

      Acquired immunodiagnostics division from GenematrixBio

      Investment : USD 0.5M

    • October

      Acquired KGMP certificate

      Listed a medical device manufacturer to MFDS

  • 2018

    • March

      Establishment of CALTH Inc.

    • April

      Acquired exclusive license for ICP technology

    • May

      Investment : USD 0.2M

    • July

      Selected for R&D project by the Ministry of SMEs and Startups

    • September

      Certified as a venture company

    • November

      Certified as a Corporate R&D Center